{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:51:39Z","timestamp":1792075899862,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"17-18","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.clinbiochem.2011.08.1148","type":"journal-article","created":{"date-parts":[[2011,9,13]],"date-time":"2011-09-13T04:00:55Z","timestamp":1315886455000},"page":"1457-1463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Plasma visfatin and retinol binding protein-4 levels in patients with type 2 diabetes mellitus and their relationship to adiposity and fatty liver"],"prefix":"10.1016","volume":"44","author":[{"given":"Olfat","family":"Shaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"El-Shehaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abir","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naglaa","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soha","family":"Talaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Katsiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri P.","family":"Mikhailidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2011.08.1148_bb0265","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1172\/JCI10842","article-title":"Obesity and insulin resistance","volume":"106","author":"Kahn","year":"2000","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0270","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","article-title":"Adipose tissue as an endocrine organ","volume":"89","author":"Kershaw","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0275","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/138945010790030992","article-title":"Should adipokines be considered in the choice of the treatment of obesity-related health problems?","volume":"11","author":"Athyros","year":"2010","journal-title":"Curr Drug Targets"},{"issue":"1","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0280","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.106.675355","article-title":"Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study","volume":"116","author":"Fox","year":"2007","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0285","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.ijo.0801871","article-title":"A pilot study of long term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding","volume":"26","author":"Th\u00f6rne","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"5","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0290","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1210\/en.2003-1336","article-title":"Comparison of the release of adipokines by adipose tissue, adipose tissue matrix and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans","volume":"145","author":"Fain","year":"2004","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0295","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/157016110790226679","article-title":"Visfatin\/PBEF and atherosclerosis-related diseases","volume":"8","author":"Filippatos","year":"2010","journal-title":"Curr Vasc Pharmacol"},{"issue":"5708","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0300","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","article-title":"Visfatin: a protein secreted by visceral fat that mimics the effects of insulin","volume":"307","author":"Fukuhara","year":"2005","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0305","first-page":"1431","article-title":"Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor","volume":"14","author":"Samal","year":"1994","journal-title":"Molec Cell Biol"},{"issue":"3","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0310","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1677\/joe.1.06211","article-title":"Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes","volume":"185","author":"Kralisch","year":"2005","journal-title":"J Endocrinol"},{"issue":"3","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0315","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.bbrc.2005.08.203","article-title":"Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats","volume":"336","author":"Choi","year":"2005","journal-title":"Biochem Biophys Res Comm"},{"issue":"10","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0320","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.2337\/diabetes.54.10.2911","article-title":"Plasma visfatin concentrations and fat depot-specific mRNA expression in humans","volume":"54","author":"Berndt","year":"2005","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0325","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1210\/jc.2005-1475","article-title":"Elevated plasma level of visfatin\/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus","volume":"91","author":"Chen","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"24","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0070","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1056\/NEJMoa054862","article-title":"Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects","volume":"354","author":"Graham","year":"2006","journal-title":"N Engl J Med"},{"issue":"7049","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0075","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature03711","article-title":"Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes","volume":"436","author":"Yang","year":"2005","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0080","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1210\/jc.2006-1815","article-title":"Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in non-obese subjects without type 2 diabetes","volume":"92","author":"Gavi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0085","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2337\/dc06-2342","article-title":"High circulating retinol binding protein 4 is associated with elevated liver fat, but not with total, subcutaneous, visceral, or intramyocellular fat in humans","volume":"30","author":"Stefan","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinbiochem.2011.08.1148_bb0090","first-page":"187","article-title":"Techniques for the measurement of visceral fat: a practical guide","volume":"17","author":"Van der Kooy","year":"1993","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"7","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0095","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/sj.ijo.0801968","article-title":"The prediction of visceral fat by dual- energy X-ray absorptiometry in the elderly: a comparison with computed tomography and anthropometry","volume":"26","author":"Snijder","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"4","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0100","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2337\/diabetes.51.4.1005","article-title":"The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentration: distinct metabolic effects of 2 fat compartments","volume":"51","author":"Cnop","year":"2002","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0009-9260(83)80303-1","article-title":"Abdominal fat assessed by computed tomography: sex difference in distribution","volume":"34","author":"Dixon","year":"1983","journal-title":"Clin Radiol"},{"issue":"1","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0330","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0022-3476(98)70175-1","article-title":"Visceral adipose tissue and cardiovascular risk factors in obese children","volume":"133","author":"Owens","year":"1998","journal-title":"J Pediatr"},{"issue":"8","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0335","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1053\/meta.2002.34035","article-title":"Intra-abdominal thickness by ultrasonography to predict risk factors for cardiovascular disease and its correlation with anthropometric measurements","volume":"51","author":"Leite","year":"1992","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0120","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2169\/internalmedicine.44.794","article-title":"A technique for the measurement of visceral fat by ultrasonography: comparison of measurements by ultrasonography and computed tomography","volume":"44","author":"Hirooka","year":"2005","journal-title":"Intern Med"},{"key":"10.1016\/j.clinbiochem.2011.08.1148_bb0340","series-title":"Obesity: preventing and managing the global epidemic, Geneva","author":"World health organization","year":"1998"},{"issue":"1","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0345","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.2337\/diacare.28.suppl_1.S37","article-title":"Diagnosis and classification of diabetes mellitus","volume":"28","author":"American Diabetes Association","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinbiochem.2011.08.1148_bb0135","first-page":"281","article-title":"Colorimetric method of determining glycosylated haemoglobin","volume":"5","author":"Danilova","year":"1986","journal-title":"Laborat\u00f3rne Delo"},{"issue":"7","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0140","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"9300","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0145","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0140-6736(02)07281-1","article-title":"Resistin, central obesity, and type 2 diabetes","volume":"359","author":"McTernan","year":"2002","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0150","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1172\/JCI19930","article-title":"Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis","volume":"113","author":"Jia","year":"2004","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0155","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1002\/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L","article-title":"Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphor ribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis","volume":"32","author":"Rongvaux","year":"2002","journal-title":"Eur J Immunol"},{"issue":"1\u20133","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0160","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0014-5793(03)00476-9","article-title":"Growth phase-dependent changes in the subcellular localization of pre-B-cell colony-enhancing factor","volume":"544","author":"Kitani","year":"2003","journal-title":"FEBS Lett"},{"issue":"5708","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0165","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1126\/science.1106933","article-title":"Visfatin: a new adipokine","volume":"307","author":"Hug","year":"2005","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0350","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/01.RES.0000173298.38808.27","article-title":"Pre-B-cell colony-enhancing factor regulates NAD+-dependent protein deacetylase activity and promotes vascular smooth muscle cell maturation","volume":"97","author":"Van der Veer","year":"2005","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0175","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1210\/jc.2005-2391","article-title":"Visfatin: a true or false trail to type 2 diabetes mellitus","volume":"91","author":"Arner","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0180","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s00125-006-0303-7","article-title":"The release of the adipokine visfatin is regulated by glucose and insulin","volume":"49","author":"Haider","year":"2006","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0185","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1210\/jc.2006-0361","article-title":"Reduced plasma visfatin\/pre-B cell colony enhancing factor in obesity is not related to insulin resistance in humans","volume":"91","author":"Pagano","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0355","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1210\/jc.2005-2248","article-title":"Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding","volume":"91","author":"Haider","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0195","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1365-2265.2009.03709.x","article-title":"Adipokines in type 1 diabetes after successful pancreas transplantation: normal visfatin and retinol-binding-protein-4, but increased total adiponectin fasting concentrations","volume":"72","author":"Stadler","year":"2010","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0200","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1210\/jc.2005-1395","article-title":"Visfatin is an adipokine, but it is not regulated by thiazolidinediones","volume":"91","author":"Hammarstedt","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0360","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.diabres.2009.03.016","article-title":"Relationship between serum retinol-binding protein 4 and visfatin and the metabolic syndrome","volume":"85","author":"CLin","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"issue":"11","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0210","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.2337\/dc06-0360","article-title":"Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes","volume":"29","author":"Cho","year":"2006","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0215","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.2337\/db06-0616","article-title":"Retinol-binding protein 4 in human obesity","volume":"55","author":"Janke","year":"2006","journal-title":"Diabetes"},{"issue":"13","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0220","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.clinbiochem.2008.06.002","article-title":"Plasma retinol binding protein is not a marker of insulin resistance in overweight subjects: a three year longitudinal study","volume":"41","author":"Lewis","year":"2008","journal-title":"Clin Biochem"},{"issue":"3","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0225","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2337\/diabetes.51.3.833","article-title":"A genome-wide scan for loci linked to plasma levels of glucose and HbA1c in a community-based sample of Caucasian pedigrees: the Framingham Offspring Study","volume":"51","author":"Meigs","year":"2002","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0230","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1365-2362.2006.01699.x","article-title":"Impact of antiretroviral therapy on visfatin and retinol binding protein 4 in HIV-infected subjects","volume":"36","author":"Schindler","year":"2006","journal-title":"Eur J Clin Invest"},{"issue":"12","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0365","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.febslet.2006.04.028","article-title":"The metabolic syndrome and adipokines","volume":"580","author":"Matsuzawa","year":"2006","journal-title":"FEBS Lett"},{"issue":"3","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0240","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1210\/edrv-10-3-308","article-title":"Retinol-binding protein: the serum transport protein for vitamin A","volume":"10","author":"Blaner","year":"1989","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0245","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/1566524053766031","article-title":"The fatty liver and insulin resistance","volume":"5","author":"Yki-J\u00e4rvinen","year":"2005","journal-title":"Curr Molec Med"},{"issue":"6","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0250","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ncpendmet0190","article-title":"Mechanisms of disease: hepatic steatosis in type 2 diabetes-pathogenesis and clinical relevance","volume":"2","author":"Roden","year":"2006","journal-title":"Natl Clin Prac Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0255","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2337\/diabetes.54.3.603","article-title":"Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes","volume":"54","author":"Petersen","year":"2005","journal-title":"Diabetes"},{"issue":"31","key":"10.1016\/j.clinbiochem.2011.08.1148_bb0260","doi-asserted-by":"crossref","first-page":"32345","DOI":"10.1074\/jbc.M313478200","article-title":"Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease","volume":"279","author":"Samuel","year":"2004","journal-title":"J Biol Chem"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912011026361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912011026361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:36:18Z","timestamp":1757864178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912011026361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":52,"journal-issue":{"issue":"17-18","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0009912011026361"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2011.08.1148","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma visfatin and retinol binding protein-4 levels in patients with type 2 diabetes mellitus and their relationship to adiposity and fatty liver","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2011.08.1148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}